Literature DB >> 23264159

Cyclofenil as a possible cause of non-arteritic anterior ischaemic optic neuropathy.

Benjamin Clarke1, Evripidis Sykakis, Dipak N Parmar.   

Abstract

A 27-year-old woman receiving the steroid drug cyclofenil as a fertility adjunct, experienced blurred vision 24 h after missing a dose and taking a double dose to 'catch up' with her therapeutic protocol. She was found to have a non-arteritic anterior ischaemic optic neuropathy with a visual hemifield defect and impaired optic nerve function, which has not since shown any recovery. This case highlights the prothrombotic potential for the drug when used above normal dosing range, and is therefore of great guidance for those initiating it as a fertility treatment, or in unlicensed use.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23264159      PMCID: PMC4544974          DOI: 10.1136/bcr-2012-007825

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

Review 1.  Cyclofenil for Raynaud's phenomenon in progressive systemic sclerosis.

Authors:  J Pope; D Fenlon; A Thompson; B Shea; D Furst; G Wells; A Silman
Journal:  Cochrane Database Syst Rev       Date:  2000

2.  Efficacy of clomiphene citrate and cyclofenil for infertile women with normal ovulatory cycles.

Authors:  S Goto; K Takakura; K Nakanishi; T Yokoi; Y Noda
Journal:  Fertil Steril       Date:  2001-08       Impact factor: 7.329

3.  Acute hepatitis induced by cyclofenil: a case report.

Authors:  G Rossi; E Gabbi; L Serra
Journal:  Ital J Gastroenterol       Date:  1992-02

Review 4.  Non-arteritic anterior ischaemic optic neuropathy: a review and update.

Authors:  Nathan M Kerr; Shenton S S L Chew; Helen V Danesh-Meyer
Journal:  J Clin Neurosci       Date:  2009-08       Impact factor: 1.961

Review 5.  The adverse effects of estrogen and selective estrogen receptor modulators on hemostasis and thrombosis.

Authors:  Arturo Artero; Juan J Tarín; Antonio Cano
Journal:  Semin Thromb Hemost       Date:  2012-10-30       Impact factor: 4.180

6.  Tamoxifen promotes superoxide production in platelets by activation of PI3-kinase and NADPH oxidase pathways.

Authors:  Vidhi P Shah; Hesum A Chegini; Susan R Vishneski; Ross V Weatherman; Peter F Blackmore; Yuliya Dobrydneva
Journal:  Thromb Res       Date:  2011-08-27       Impact factor: 3.944

7.  [A 3d case of hepatitis caused by cyclofenil in Lyons].

Authors:  A Bergeret; F Tolot
Journal:  Gastroenterol Clin Biol       Date:  1986-11

8.  [Acute hepatitis caused by cyclofenil (Ondogyne). Apropos of 2 cases].

Authors:  B Bouvet; P Rocas; P Paliard; R Brette; C Trépo
Journal:  Gastroenterol Clin Biol       Date:  1985-12

Review 9.  Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.

Authors:  Patricia A Ganz; Stephanie R Land
Journal:  Menopause       Date:  2008 Jul-Aug       Impact factor: 2.953

10.  [Cyclofenil-induced acute hepatitis. A retrospective diagnosis of a case during acute hepatitis B].

Authors:  M Mengoli; M Marchi; S Tolomelli; A Bagnulo
Journal:  Recenti Prog Med       Date:  1991-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.